LUGANO, Switzerland and SAN DIEGO, Jan. 11, 2018 /PRNewswire/ — Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today…












